Highlights Celyad Oncology SA

Equities

CYAD

BE0974260896

Biotechnology & Medical Research

Real-time Euronext Bruxelles Other stock markets 07:05:47 2026-01-23 am EST			5-day change	1st Jan Change
0.1700 ^EUR	-0.58%		-2.86%	-

25-09-30	Celyad Oncology to Sell Belgian Research Facility for EUR3 Million	MT
25-09-29	Celyad Oncology announces research facility divestiture	RE

Highlights

25-09-30	Celyad Oncology to Sell Belgian Research Facility for EUR3 Million	MT
25-09-29	Celyad Oncology announces research facility divestiture	RE
25-09-28	An undisclosed buyer agreed to acquire Research facility?s equipment and office furniture in Mont-Saint-Guibert, Belgium of Celyad Oncology SA for ?3 million.	CI
25-09-25	Celyad Oncology SA Reports Earnings Results for the Half Year Ended June 30, 2025	CI
25-04-02	Celyad Oncology SA Reports Earnings Results for the Full Year Ended December 31, 2024	CI
25-02-18	Celyad Oncology Announces the Publication of the Preclinical and Clinical Data of CYAD-211 Providing Proof-Of-Concept of Its miRNA-Based shRNA Platform	CI
24-09-13	Celyad Oncology SA Reports Earnings Results for the Half Year Ended June 30, 2024	CI
24-04-04	Celyad Oncology SA Reports Earnings Results for the Full Year Ended December 31, 2023	CI
24-02-09	Celyad Oncology Seeks Termination of Reporting Obligations to US SEC	MT
23-09-04	Celyad Oncology SA Reports Earnings Results for the Half Year Ended June 30, 2023	CI
23-05-16	Celyad Oncology's American Depositary Shares to Be Delisted from Nasdaq	MT
23-05-15	Celyad Oncology Receives Delisting Notice From Nasdaq	MT
23-05-05	Forecast-Beating Apple Results Lift Exchange-Traded Funds, Equity Futures Pre-Bell Friday	MT
23-05-05	Belgium's Celyad Oncology to Delist ASDs from Nasdaq	MT
23-04-04	Celyad Oncology in Breach of Nasdaq's Listing Rule	MT
23-02-09	Celyad Oncology Announces Publication of Data from Its Phase 1 Think Study of CYAD-01	CI
22-10-12	Celyad Oncology Provides Update on Clinical Trial Programs	CI
22-09-29	Cellistic completed the acquisition of Manufacturing Business Unit of Celyad Oncology from Celyad Oncology SA.	CI
22-09-20	Celyad Oncology to Divest Cell Therapy Facility in Belgium for $6 Million	MT
22-09-19	Cellistic emtered into asset purchase agreement to acquire Manufacturing Business Unit of Celyad Oncology from Celyad Oncology SA for ?6 million.	CI
22-08-05	Celyad Oncology SA Reports Earnings Results for the Half Year Ended June 30, 2022	CI
22-08-01	Celyad Oncology Says FDA Lifts Clinical Hold on Phase 1b Trial of Colorectal Cancer Combination Therapy	MT
22-08-01	Celyad Oncology Sa Announces Fda Lifts Clinical Hold of Cyad-101-002 Phase 1B Trial	CI
22-05-06	Celyad Oncology SA Reports Earnings Results for the First Quarter Ended March 31, 2022	CI
22-03-24	Celyad Oncology SA Reports Earnings Results for the Full Year Ended December 31, 2021	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages MarketScreener Editorial Features MarketScreener Strategies Trading Ideas

Highlights Celyad Oncology SA

Equities

CYAD

BE0974260896

Biotechnology & Medical Research

Highlights

Filters